Notice: Educational content. This site contains affiliate links — we may earn a commission at no extra cost to you. Not medical advice. Consult your physician before starting any medication.
Telehealth providers, GLP-1 medications, weight loss programs — independently reviewed with real pricing, FDA standing, clinical citations, and zero hype.
8 providers compared honestly
Updated May 4, 2026 · 12 min read
The compounded GLP-1 market changed dramatically in 2026 — FDA warnings, new oral pills, dropping prices, 30+ active providers. Here's a transparent ranking of SkinnyRx, Hims, GobyMeds, Pomegranate, Coreage RX, Mochi, Brello, Get Thin MD.
TRIUMPH-4: 28.7% weight loss · NDA Q4 2026 · Approval late 2027
Updated May 4, 2026 · 11 min read
Eli Lilly's TRIUMPH-4 just delivered the highest weight loss in any Phase 3 GLP-1 trial. Here's the realistic FDA approval timeline based on disclosed Phase 3 schedule and PDUFA review windows. Live tracker.
28.7% vs 22.5% weight loss · the 6-point gap explained
May 4, 2026 · 10 min read
Same drug class, different molecular targets. The 6 percentage point gap isn't random — it's what happens when you add a third receptor (glucagon) to GLP-1 + GIP. Strategic recommendation included.
Hims vs Mochi vs SkinnyRx · Compounded vs brand evidence · Side effect timelines · Maintenance protocols · How to switch providers · Phase 3 retatrutide updates · And many more.
Each review backed by clinical citations and real-world data.